AI Clinical-Grade Motion Analysis for Rehab and Fitness
Our proprietary AI engine, FlexMSK, analyses skeletal movement in real time using only a smartphone camera, making clinical-grade biomechanical analysis accessible to everyone, everywhere.
Exercise Library
Pre-built
App
Cloud
Storage
No
wearables
Trusted by
More effective and efficient MSK treatment at a lower cost.
More engaging health programmes with less admin work.
Motion Tracking (Hrs)
Active Users
Satisfaction
Strategic Collaboration with School of Rehabilitation Sciences in Southern Medical University (中国南方医科大学康复医学院)
Being the partner of Hong Kong Science & Technology Parks
Being the Ecosystem Partner with HKSAR Hospital Authority IT Innovation Office
Patent
FlexMSK has been patented with the registration number HK30105427.
Launching FlexMSK to NGOs
Expanding accessible MSK care by equipping NGOs with AI technology to provide affordable, high-quality rehabilitation for underserved and remote populations.
Appointed Platform
FlexMSK is appointed platform for China Rehabilitation Medical Schools’ Digital Medicine Education Program & 2025 China Rehabilitation Medical Student Competition
Launch in Schools
FlexMSK effortlessly fulfills MVPA60 initiatives, replacing time-consuming admin work with real-time digital reports.
RaphAI is partnering with PolyU to co-develop AI-driven recognition technologies, setting new clinical standards for digital recovery.
Medical Research Result
A 2026 randomised controlled trial published in the Journal of Medical Internet Research (JMIR) found that RaphAI’s AI-assisted telerehabilitation works effectively on hypertension patients.
Our FlexMSK AI software is now being deployed by the Hospital Authority of Hong Kong SAR, bringing advanced real-time monitoring and data-driven recovery to the city’s public physiotherapy services.
RaphAI is positioned to disrupt the $26B MSK market in Asia with a more sustainable healthcare infrastructure for an aging population.
And let AI bring you to the next level.